Imprinted genes in liver carcinogenesis

FASEB Journal

Volumn 11, Issue 1, 1997, Pages 60-67

  De Souza, Angus T ^a   Yamada, Tomoya ^b   Mills, Jeremy J ^c   Jirtle, Randy L ^c  

^a ASTRAZENECA   (United Kingdom)

^b SUMITOMO CHEMICAL CO LTD   (Japan)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

genomic imprinting; IGF2; M6P IGF2R; tumor suppressor gene

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

CANCER INHIBITION; CANCER RISK; GENOME IMPRINTING; LIVER CARCINOGENESIS; MITOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

EID: 0031049935     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.1.9034167     Document Type: Review

References (136)

1. Latham, K. E., McGrath, J., and Solter, D. (1995) Mechanistic and developmental aspects of genetic imprinting in mammals. Int. Rev. Cytol. 160, 53-98
2. Penny, C. D., Kay, G. F., Sheardown, S. A., Rastan, S., and Brockdorff, N. (1996) Requirement of Xist in X chromosome inactivation. Nature (London) 379, 131-137
3. Gold, J. D., and Pedersen, R. A. (1994) Mechanism of genomic imprinting in mammals. Curr. Top. Dev. Biol. 29, 227-280
4. Razin, A., and Cedar, H. (1994) DNA methylation and genomic imprinting. Cell 77, 473-476
5. Hendrich, B. D., and Huntington, F. W. (1995) Epigenetic regulation of gene expression: the effect of altered chromatin structure from yeast to mammals. Hum. Mol. Genet. 4, 1765-1777
6. De-Groot, N., and Hochberg, A. (1993) Gene imprinting during placental and embryonic development. Mol. Reprod. Dev. 36, 390-106
7. Deal, C. L. (1995) Parental genomic imprinting. Curr. Opin. Pediatr. 7, 445-458
8. Kuroiwa, Y., Kaneko-Ishino, T., Kagitani, F., Kohda, T., Li, L. L., Tada, M. Suzuki, R., Yokoyama, M., Shiroishi, T., Wakana, S., Barton, S. C., Ishino, R., and Surani, M. A. (1996) Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nat. Genet. 12, 186-190
9. Kankeko-Ishino, T., Kuroiwa, Y., Miyoshi, N., Kohda, T., Suzuki, R., Yokoyama, M., Viville, S., Barton, S. C., Ishino, F., and Surani, M. A. (1995) Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat. Genet. 11, 52-59
10. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat. Genet. 11, 204-206
11. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev. 9, 650-662
12. Pearsall, R. S., Shibata, H., Brozowska, A., Yoshino, K., Okuda, K., deJong, P. J., Plass, C., Chapman, V. M., Hayashizaki, Y., and Held, W. A. (1996) Absence of imprinting in U2AFBPL, a human homologue of the imprinted mouse gene U2afbp-rs. Biochem. Biophys. Res. Commun. 222, 171-177
13. Williamson, C. M., Schofield, J., Dutton, E. R., Seymour, A., Beechey, C. V., Edwards, Y. H., and Peters, J. (1996) Clomerular-specific imprinting of the mouse Gsα gene: how does this relate to hormone resistance in Albright hereditary osteodystrophy? Genomics, 36, 280-287
14. Plass, C., Shibata, H., Kalcheva, I., Mullins, L., Kotelevtseva, N., Mullins, J., Kato, R., Sasaki, H., Hirotsune, S., Okazaki, Y., Held, W. A., Hayashizaki, Y., and Chapman, V. M. (1996) Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat. Genet. 14, 106-109
15. KIP2 and its reduced expression in Wilm's tumors. Hum. Mol. Genet. 5, 783-788
16. Nishita, Y., Yoshida, I., Sado, K., and Takagi, N. (1996) Genomic imprinting and chromosomal localization of the human MEST gene. Genumics 36, 539-542
17. Kalscheuer, V. M., Mariman, E. C., Schepens, M. T., Rehder, H., and Ropers, H.-H. (1993) The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat. Genet. 5, 74-78
18. Ogawa, O., McNoe, L., A., Eccles, M. R., Morison, I. M., and Reeve, A. E. (1993) Human insulin-like growth factor type I and type II receptors are not imprinted. Hum. Mol. Genet. 2, 2163-2165
19. Xu, Y., Goodyer, C. G., Deal, C., and Polychronakos, C. (1993) Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun. 197, 747-754
20. McGrath, J., and Solter, D. (1984) Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37, 179-183
21. Surani, M. A., Barton, S. C., and Norris, M. I., (1984) Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature (London) 308, 548-550
22. Haig, D., and Graham, C. (1991) Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64, 1015-1046
23. Barlow, D. P., Stöger, R., Herrmann, B. G., Saito, K., and Schweifer, N. (1991) The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature (London) 349, 84-87
24. DeChiara, T. M., Efstratiadis, A., and Robertson, E. J. (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (London) 345, 78-80
25. Tycko, B. (1994) Genomic imprinting: mechanism and role in human pathology. Am. J. Pathol. 144, 431-443
26. Cassidy, S. B. (1995) Uniparental disomy and genomic imprinting as causes of human genetic disease. Environ. Mol. Mutagen. 25, 13-20
27. Linder, D., McCaw, B. K., and Hecht, F. (1975) Parthenogenetic origin of benign ovarian teratomas. N. Engl. J. Med. 292, 63-66
28. Wake, N., Fujino, T., Hoshi, S., Shinkai, N., Sakai, K., Kato, H., Hashimoto, M., Yasuda, T., Yamada, H., and Ichinoe, K. (1987) The propensity to malignancy of dispermic heterozygous moles. Placenta 8, 319-326
29. Toguchida, J., Ishizaki, K., Sasaki, M. S., Nakamura, Y., Ikenaga, M., Kato, M., Sugimot, M., Kotoura, Y., and Yamamuro, T. (1989) Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature (London) 338, 156-158
30. Katz, F., Webb, D., Gibbons, B., Reeves, B., McMahon, C., Cheselles, J., and Mitchell, C. (1992) Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7. Br. J. Haematol. 80, 332-336
31. Nicholls, R. D., Knoll, J. H. M., Butler, M. G., Karam, S., and Lalande, N. (1989) Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature (London) 342, 281-285
32. Nicholls, R. D. (1993) Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review. Am. J. Med. Genet 46, 16-25
33. Henry, I., Bonaiti-Pellie, C., Chehensse, V., Beldjord, C., Schwartz, C., Utermann, G., and Junien, C. (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (London) 351, 665-667
34. Harper, M. E., Ullrich, A., and Saunders, G. F. (1981) Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc. Natl. Acad. Sci. USA 78, 4458-4460
35. Brissenden, J. E., Ullrich, A., and Franke, U. (1984) Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature (London) 310, 781-784
36. Giannoukakis, N., Deal, C., Paquette, J., Goodyer, C. G., and Polychronakos, C. (1993) Parental genomic imprinting of the human IGF2 gene. Nat. Genet. 4, 98-101
37. Ohlsson, R., Nystrom, A., Pfeifer-Ohlsson, S., Fobonen, V., Hedbourg, F., Schofield, P., Flam, F., and Ekstrom, T. J. (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat. Genet. 4, 94-97
38. Zhang, Y., and Tycko, B. (1992) Monoallelic expression of the human H19 gene. Nat. Genet. 1, 40-44
39. Rachmilewitz, J., Goshen, R., Ariel, L. Schneider, T., De Groot, N., and Hochberg, A. (1992) Parental imprinting oi the human H19 gene. FEBS Lett. 309, 23-28
40. Pettenati, M. J., Haines, J. L., Higgins, R. R., Wapper, R. S., Palmer, C. G., and Weaver, D. D. (1986) Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum. Genet. 74, 143-154
41. Moulton, T., Crenshaw T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T., Kraus, W., and Tycko, B. (1994) Epigenetic lesions at the H19 locus in Wilm's tumor patients. Nat. Genet. 7, 440-447
42. Steenman, M. J. C., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilm's tumor. Nat. Genet. 7, 433-439
43. Taniguchi, T., Sultan, M. J., Osamu, O., and Reeve, A. (1995) Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilm's tumor. Proc. Natl. Acad. Sci. USA 92, 2159-2163
44. Leighton, P. A., Ingram, I. S., Eggenschwiler, J., Efstratiadis, A., and Tilghman, S. M. (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature (London) 375, 34-39
45. Han, Y., Crenshaw, T., Moulton, T., Newcomb, E., and Tycko, B. (1993) Tumour-suppressor activity of H19 RNA. Nature (London) 365, 764-767
46. Rastmejad F., Conboy, M. J., Rando, T. A., and Blau, H. M. (1993) Tumor suppression by RNA from the 3′ untranslated region of alpha-tropomyosin. Cell 75, 1107-1118
47. Fan, H., Villigas, C., Huang, A., and Wright, J. A. (1996) Suppression of malignancy by the 3′ untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs. Cancer Res. 56, 4366-4369
48. Czech, M. P. (1989) Signal transmission by the insulin-like growth factors. Cell 59, 235-238
49. Osborne, C. K., Coronado, E. B., Kitten, L. J., Arteaga, C. I., Fuqua, S. A. W., Ramasharma, K., Marshall, M., and Li, C. H. (1989) Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3, 1701-1709
50. Moxham, C., and Jacobs, S. (1992) Insulin-like growth factor receptors. In The Insulin-like Growth Factors (Schofield, P. N., ed) pp. 80-109, Oxford University Press, Oxford
51. Cohick, W. S., and Clemmons, D. R. (1993) The insulin-like growth factors. Annu. Rev. Physiol. 55, 131-153
52. Jennische, E., Isgaard, J., and Isaksson, O. G. P. (1992) Local expression of insulin-like growth factors during tissue growth and regeneration. In The Insulin-Like Growth Factors: Structure and Biological Functions (Schofield, P. N., ed) pp. 221-239, Oxford Medical Publications, Oxford
53. Han, V. K. M., and Hill, D. J. (1992) The involvement of insulin-like growth factors in embryonic and fetal development. In The Insulin-Like Growth Factors: Structure and Biological Functions (Schofield, P. N., ed) pp. 178-220, Oxford Medical Publications, Oxford
54. Daughaday, W. H., and Rotwein, P. (1989) Insulin-like growth factors I and II. peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrinol. Rev. 10, 68-91
55. Humbel, R. E. (1990) Insulin-like growth factors I and II. Eur. J. Biochem. 190, 445-462
56. Vu, T. H., and Hoffman, A. R. (1994) Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature (London) 371, 714-177
57. Ekstrom, T. J. (1994) Parental imprinting and the IGF2 gene. Horm. Res. 42, 176-181
58. Su, T.-S., Liu, W.-Y., Han, S.-H., Jansen, M., Yang-Fen, T. L., P'eng, F.-K., and Chou, C.-K. (1989) Transcripts of the insulin-like growth factors I and II in human hepatoma. Cancer Res. 49, 1773-1777
59. Shapiro, E. T., Bell, G. I., Polonsky, K. S., Rubenstein, A. H., Kew, M. C., and Tager, H. S. (1990) Tumor hypoglycemia: relationship to high molecular weight insulin-growth factor-II. J. Clin. Invest. 85, 1672-1679
60. Arteaga, C. L. (1992) Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res. Treat. 22, 101-106
61. Yee, D., Cullen, K. J., Paik, S., Perdue, J. F., Hampton, B., and Schwartz, A. (1988) Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res. 48, 6691-6696
62. Lambert, S., Carlisi, A., Collette, J., Franchimont, P., and Gol-Winkler, R. (1992) Insulin-like growth factor II in two human colon-carcinoma cell lines: gene structure and expression, and protein secretion. Int. J. Cancer 52, 404-408
63. Lahm, H., Suardet, L., Laurent, P. L., Fischer, J. R., Ceyhan, A., Givel, J.-C., and Odartchenko, N. (1992) Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br. J. Cancer 65, 341-346
64. Lambert, S., Collette, J., Gillis, J., Franchimont, R., Desaive, C., and Gol-Winkler, R. (1991) Tumor IGF-II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the gene. Int. J. Cancer 48, 826-830
65. Lambert, S., Vivario, J., Boniver, J., and Gol-Winkler, R. (1990) Abnormal expression and structural modification of the insulin-like growth-factor-11 gene in human colorectal tumors. Int. J. Cancer 46, 405-410
66. Havemann, K., Rotsch, M., Schoneberger, H. J., Erbil, C., Hennig, C., and Jaques, G. (1990) Growth regulation by insulin-like growth factors in lung cancer. J. Steroid Biochem. Mol. Biol. 37, 877-882
67. Melino, G., Stephanou, A., Annicchiarico-Petruzzelli, M., Finazzi-Agró, A., Knight, R. A., and Lightman, S. L. (1992) IGF-II mRNA expression in LI human glioblastoma cell line parallels cell growth. Neurosci. Lett. 144, 23-28
68. Bates, P., Fisher, R., Ward, A., Richardson, L., Hill, D. J., and Graham, C. F. (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br. J. Cancer 72, 1189-1193
69. Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., and Hintz, R. (1994) Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem. 269, 13779-13784
70. Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., and Merlino, G. T. (1990) TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of lhe mammary gland and pancreas. Cell 61, 1137-1146
71. Smith, G. H., Sharp, R., Kordon, E. C., Jhappan, C., and Merlino, G. (1995) Transforming growth factor-α promotes mammary tumongenesis through selective survival and growth of secretory epithelial cells. Am. J. Pathol. 147, 1081-1096
72. Westley, B. R., and May, F. E. B. (1995) Insulin-like growth factors: the unrecognised oncogenes. Br. J. Cancer 72, 1065-1066
73. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., and Feinberg, A. P. (1993) Relaxation of imprinted genes in human cancer. Nature (London) 362, 747
74. Ogawa, O., Eccles M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., and Reeve, A. E. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (London) 362, 749-751
75. Zhan, S., Shapiro, D. N., and Helman, L. J. (1994) Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J. Clin. Invest. 94, 445-448
76. Pedone, P. V., Tirabosco, R., Cavazzana, A. O., Ungaro, P., Basso, G., Luksch, R., Carli, M., Bruni, C. B., Frunzio, R., and Riccio, A. (1994) Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum. Mol. Genet. 3, 1117-1121
77. Suzuki, H., Veda, R., and Takahashi, T. (1994) Altered imprinting in lung cancer. Nat. Genet. 6, 332-333
78. Vu, T. H., Yballe, C., Boonyanit, S., and Hoffman, A. R. (1995) Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J. Clin. Endocrinol. Metab. 80, 1670-1676
79. Barrois, M., Theodore, C., Court, B., Perrin, J. L., and Riou, C. (1996) Loss of imprinting of H19 and IGF2 genes associated with overexpression and hypomethylation of H19 in testicular germ cell tumors. Proc. Am. Assoc. Cancer Res. 37, 598
80. Ahomadegbe, J. C., Tourpin, S., Douc-Rasy, S., Barreau-Pouhaer, L., and Riou, G. (1996) Loss of imprinting of H19 and IGF2 genes associated with hypomethylation in invasive breast carcinomas. Proc. Am. Assoc. Cancer Res. 37, 598
81. Davies, S. M. (1993) Maintenance of genomic imprinting at the IGF2 locus in hepatoblastnma. Cancer Res. 53, 4781-4783
82. Rainier S., Dobry, C. J., and Feinberg, A. P. (1995) Loss of imprinting in hepatoblastoma. Cancer Res. 55, 1836-1838
83. Li, K., Adam, G., Cui, H., Sandstedt, B., Ohlsson, R., and Ekstrom, T. J. (1995) Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene 11, 221-229
84. Thorgeirsson, S. S. (1995) Stem Cells and Hepatocarcinogenesis. In Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms (Jirtle, R. L., ed) pp. 99-112, Academic Press, San Diego
85. Morgan, D. O. Edman, J. C., Standring, D. N., Fried, V. A., Smith, M. C., Roth, R. A., and Rutter, W. J. (1987) Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (London) 329, 301-307
86. Kornfeld, S. (1992) Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu. Rev. Biochem. 61, 307-330
87. Kiess, W., Greenstein, L. A., White, R. M., Lee, L., Rechler, M. M., and Nissley, S. P. (1987) Type II insulin-like growth factor receptor is present in rat serum. Proc. Natl. Acad. Sci. USA 84, 7720-7724
88. MacDonald, R. C., Tepper, M. A., Clairmont, C. B., Perregaux, S. B., and Czech, M. P. (1989) Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J. Biol. Chem. 264, 3256-3261
89. Dahms, N. M. (1996) Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition. Biochem. Soc. Trans. 24, 136-141
90. Pilia, G., Hughes-Benzie, R. M., MacKenzie, A., Baybayan, P., Chen, E. Y., Huber, R., Neri, G., Cao, A., Forabosco, A., and Schlessinger, D. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12, 241-247
91. Ikezu, T., Okamoto, T., Giambarella, U., Yokota, T., and Nishimoto, I. (1995) In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G-proteins. J. Biol. Chem. 270, 29224-29228
92. Korner, C., Nurnberg, B., Uhde, M., and Braulke, T. (1995) Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. J. Biol. Chem. 270, 287-295
93. Johnson, K. F., and Kornfeld, S. (1992) The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-11 receptor has two signals for lysosomal enzyme sorting in the Golgi. J. Cell Biol. 119, 249-257
94. Ludwig, T., Ovitt, C. E., Bauer, I., Hollinshead, M., Remmler, J., Lobel, P., Ruther, U., and Hoflack, B. (1993) Targeted disruption of the mouse cation-dependent mannose 6-phosphate receptor results in partial mis-sorting of multiple lysosomal enzymes. EMBO J. 12, 5225-5235
95. Purchio, A. F., Cooper, J. A., Brunner, A. M., Lioubin, M. N., Gentry, L. E., Kovacina, K. S., Roth, R. A., and Marquardt, H. (1988) Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta-1 precursor. J. Biol. Chem. 263, 14211-14215
96. Kovacina, K. S., Steele-Perkins, G., Purchio, A. F., Lioubin, M., Miyazono, K., Heldin, C.-H., and Roth, R. A. (1989) Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem. Biophys. Res. Commun. 160, 393-403
97. Dennis, P. A., and Rifkin, D. B. (1991) Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88, 580-584
98. Wang, X.-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F., and Weinberg, R. A. (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell 67, 797-805
99. Lopez-Cassillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., and Massagué, J. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67, 785-795
100. Bassing, C. H., Tingling, J. M., Howe, D. J., Wang, T., He, W. W., Gustafson, M. L., Shah, P., Donahoe, P. K., and Wang, X.-F. (1994) A transforming growth factor β type I receptor that signals to activate gene expression. Science 263, 87-89
101. Lin, H. Y., Wang, X.-F., Hg-Eaton, E., Weinberg, R. A., and Lodish, H. F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785
102. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994) Mechanism of activation of the TGF-β receptor. Nature (London) 370, 341-347
103. Massagué, J. (1992) Receptors for the TGF-β family. Cell 69, 1067-1070
104. Kim, Y. L. Ahn, H.-J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J.-H., Kato, M., and Lee, C. (1996) Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res. 56, 44-48
105. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338
106. Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., and Brattain, M. G. (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270, 22044-22049
107. Souza, R.F., Appel, R., Yin, J., Wang, S., Smolinski, K.N., Abraham, J.M., Zou, T.-T., Shi, Y.-Q., Lie, J., Cottrell, J., Biden, K., Simms, L., Leggett, B., Lynch, P.M., Frazier, M., Powell, S.M., Harpaz, N., Sugimura, H., Young, J., and Meltzer, S.J. (1996) The insulin-like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours. Nat. Genet. 14, 255-257
108. Jirtle, R. L., Hankins, G. R., Reisenbichler, H., and Boyer, I. J. (1994) Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 15, 1473-1478
109. Jirtle, R. L., Haag, J. D., Ariazi, E. A., and Gould, M. N. (1993) Increased mannose 6-phosphate/insulin-like growth factor II receptor and TGF-β1 levels during monoterpene-induced regression of mammary tumors. Cancer Res. 53, 3849-3852
110. Mills, J. J., Chari, R. S., Boyer, I. J., Gould, M. N., and Jirtle, R. L. (1995) Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 55, 979-983
111. Sue, S. R., Chari, R. S., Kong, F.-M., Mills, J. J., Fine, R. L., Jirtle, R. L., and Meyers, W. C. (1995) Transforming growth factor beta receptors and mannose 6-phosphate/insulin-like growth factor II receptor expression in human hepatocellular carcinomas. Ann. Surg. 222, 171-178
112. Lasko, D., Cavenee, W., and Nordenskkjöld, M. (1991) Loss of constitutional heterozygosity in human cancer. Annu. Rev. Genet. 25, 281-314
113. Laureys, G., Barton, D. F., Ullrich, A., and Francke, U. (1988) Chromosomal mapping of the gene for the type II insulin-like growth factor receptor/cation-indepemlent mannose 6-phosphate receptor in man and mouse. Genomics 3, 224-229
114. De Souza, A. T., Hankins, G. R., Washington, M. K., Fine, R. L., Orton, T. C., and Jirtle, R. L. (1995) Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 10, 1725-1729
115. De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., and Jirtle, R. L. (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 11, 447-449
116. Yamada, T., De Souza, A. T., Finkelstein, S., Reddy, R., and Jirtle, R. L. (1996) Mannose 6-phosphate/insulin-like growth factor-II receptor: a tumor suppressor gene in human liver cancer associated with viral hepatitis and cirrhosis. Hepatology 24, 358A
117. Dutrillaux, B., Gerbault-Suereau, M., and Zafrani, B. (1990) Characterization of chromosomal abnormalities in human breast cancer: a comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet. Cytogenet. 49, 203-217
118. Mars, W. M., and Saunders, G. F. (1990) Chromosomal abnormalities in human breast cancer. Cancer Metastasis Rev. 9, 35-43
119. Devilee, P., van Vliet, M., van Sloun, P., Dijkshoorn, N. K., Hermans, J., Pearson, P. L., and Cornelisse, C. J. (1991) Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6, 1705-1711
120. Lee, J. H., Kavanagh, J. J., Wildrick, D. M., Wharton, J. T., and Blick, M. (1990) Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res. 50, 2724-2728
121. Saito, S., Saito, H., Koi, S., Sagae, S., Kudo, R., Saito, J., Noda, K., and Nakamura, Y. (1992) Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res. 52, 5815-5817
122. Foulkes, W. D., Ragoussis, J., Stamp, G. W., Allan, G. J., and Trowsdale, J. (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer 67, 551-559
123. Millikin, D., Meese, F., Vogelstein, B., Wilkowski, C., and Trent, J. (1991) Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 51, 5449-5453
124. Gaidano, G., Hauptschein, R. S., Parsa, N. Z., Offit, K., Rao, P. H., Lenoir, G., Knowles, D. M., Changanti, R. S., and Dalla-Favera, R. (1992) Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80, 1781-1787
125. Morita, R., Saito, S., Ishikawa, J., Ogawa, O., Yoshida, O., Yamakawa, K., and Nakamura, Y. (1991) Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res. 51, 5817-5820
126. Hankins, G. R., De Souza, A. T., Bentley, R. C., Patel, M. R., Marks, J. R., Iglehart, J. D., and Jirtle, R. L. (1996) M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12, 2003-2009
127. Wang, Z.-Q., Fung, M. R., Barlow, D. P., and Wagner, E. F. (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/M6pr gene. Nature (London) 372, 464-467
128. Filson, A. J., Louvi, A., Efstratiadis, A., and Robertson, E. J. (1993) Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development 118, 731-736
129. Stöger, R., Kubicka, P., Liu, C.-G., Kafri, T., Razin, A., Cedar, H., and Barlow, D. P. (1993) Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73, 61-71
130. Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72
131. Leff, S. E., Brannan, C. I., Reed, M. L., Ozcelik, T., Francke, U., Copeland, N. G., and Jenkins, N. A. (1992) Maternal imprinting of mouse Snrpn gene and conserved linkage homology with the human Prader-Willi syndrome region. Nat. Genet. 4, 259-264
132. Bartolomei, M. S., Zemel, S., and Tilghman, S. M. (1991) Parental imprinting of the mouse H19 gene. Nature (London) 351, 153-155
133. Li, E., Beard, C., and Jaenisch, R. (1993) Role of DNA methylation in genomic imprinting. Nature (London) 366, 362-365
134. Smrzka, O. W., Fae, I., Stöger, R., Kurzbauer, R., Fischer, G. F., Henn, T., Weith, A., and Barlow, D. P. (1995) Conservation of a maternal-specific methylation signal at the human IGF2R locus. Hum. Mol. Genet. 4, 1945-1952
135. Rumbsby, P. C. (1996) Vital factors in liver cancer. Hum. Exp. Toxicol. 15, 539-540
136. Mills, J. J., Jirtle, R. L., and Boyer, I. J. (1995) Mechanisms of liver tumor promotion. In Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms (Jirtle, R. L., ed) pp. 199-226, Academic Press, San Diego